{"id":11592,"date":"2025-10-01T09:47:33","date_gmt":"2025-10-01T07:47:33","guid":{"rendered":"http:\/\/advantum.com\/?p=11592"},"modified":"2025-11-10T11:01:52","modified_gmt":"2025-11-10T10:01:52","slug":"cinclus-pharma-valjer-advantum-som-tjanst","status":"publish","type":"post","link":"https:\/\/advantum.com\/en\/cinclus-pharma-valjer-advantum-som-tjanst\/","title":{"rendered":"Cinclus Pharma chooses Advantum as a service"},"content":{"rendered":"
\"\"<\/figure>\n\n\n\n

Cinclus Pharma has chosen Advantum as a service to ensure quality and streamline its document management. With Advantum as a service, Cinclus Pharma subscribes to a modern web-based environment with very high security. Thanks to Advantum's service solution, Cinclus Pharma does not need to make any own investment in hardware and licenses. With Advantum, Cinclus Pharma receives powerful system support for creating, maintaining and archiving documentation throughout the entire process.<\/p>\n\n\n\n

Cinclus Pharma is a Swedish clinical-stage pharmaceutical company developing molecules for the treatment of acid-related diseases. Their lead drug candidate linaprazan glurate is being developed for the treatment of severe gastroesophageal reflux disease (GERD).<\/p>\n\n\n\n

Read more about Advantum here<\/a>. <\/p>\n\n\n\n

Read more about Cinclus Pharma here<\/a>.<\/p>\n\n\n\n

For more information please contact:
Christina Hall<\/strong>
InfoTech Scandinavia AB
christina.hall@infotech.se
+46 709 67 00 15<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

Cinclus Pharma har valt Advantum som tj\u00e4nst f\u00f6r att kvalitetss\u00e4kra och effektivisera sin dokumenthantering. Med Advantum som tj\u00e4nst prenumererar Cinclus Pharma p\u00e5 en modern webbaserad milj\u00f6 med v\u00e4ldigt h\u00f6g s\u00e4kerhet. Tack vare Advantums tj\u00e4nstel\u00f6sning beh\u00f6ver Cinclus Pharma inte ta n\u00e5gon egen investering i h\u00e5rdvara och licenser. Med Advantum f\u00e5r Cinclus Pharma ett kraftfullt systemst\u00f6d f\u00f6r […]<\/p>\n","protected":false},"author":3,"featured_media":11601,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-11592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nyheter"],"_links":{"self":[{"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/posts\/11592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/comments?post=11592"}],"version-history":[{"count":3,"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/posts\/11592\/revisions"}],"predecessor-version":[{"id":11596,"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/posts\/11592\/revisions\/11596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/media\/11601"}],"wp:attachment":[{"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/media?parent=11592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/categories?post=11592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/advantum.com\/en\/wp-json\/wp\/v2\/tags?post=11592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}